Effects of sub-chronic nabiximols on biological markers of individuals undergoing a clinical trial for the treatment of cannabis use disorder.

Wang, Ruoyu; Trigo, Jose M; Le Foll, Bernard

Wang, Ruoyu; Trigo, Jose M; Le Foll, Bernard.

Afiliação

Wang R; Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health Toronto, Ontario, Canada.
Trigo JM; Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto Toronto, Ontario, Canada.
Le Foll B; Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health Toronto, Ontario, Canada.

Am J Transl Res ; 15(8): 5228-5238, 2023.

Article em En | MEDLINE | ID: mdl-37692969

Palavras-chave

Nabiximols; blood marker; cannabis use disorder; treatment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Revista: Am J Transl Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google